Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sara M Maloney"'
Autor:
Emily M Astarita, Sara M Maloney, Camden A Hoover, Bronwyn J Berkeley, Monica K VanKlompenberg, T Murlidharan Nair, Jenifer R Prosperi
Publikováno v:
PLoS ONE, Vol 16, Iss 8, p e0255738 (2021)
Adenomatous Polyposis Coli (APC) is lost in approximately 70% of sporadic breast cancers, with an inclination towards triple negative breast cancer (TNBC). TNBC is treated with traditional chemotherapy, such as paclitaxel (PTX); however, tumors often
Externí odkaz:
https://doaj.org/article/79747361a6854962ba0092eaf85574a0
Publikováno v:
Cancer Research. 81:PS16-21
Adenomatous Polyposis Coli (APC) is a multi-domain tumor suppressor with multiple binding partners, including β-catenin, axin, and microtubules. APC is lost in many epithelial cancers, including up to 70% of sporadic breast cancers, with a tendency
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65fdf43f2a3b41564f952df5427c5dfd
https://doi.org/10.1158/1538-7445.sabcs20-ps16-21
https://doi.org/10.1158/1538-7445.sabcs20-ps16-21
Autor:
T. Murlidharan Nair, Sara M. Maloney, Monica K. VanKlompenberg, Bronwyn J. Berkeley, Emily Astarita, Jenifer R. Prosperi, Camden A. Hoover
Publikováno v:
PLoS ONE, Vol 16, Iss 8 (2021)
PLoS ONE
PLoS ONE, Vol 16, Iss 8, p e0255738 (2021)
PLoS ONE
PLoS ONE, Vol 16, Iss 8, p e0255738 (2021)
Adenomatous Polyposis Coli (APC) is lost in approximately 70% of sporadic breast cancers, with an inclination towards triple negative breast cancer (TNBC). TNBC is treated with traditional chemotherapy, such as paclitaxel (PTX); however, tumors often
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5cc00f9546043b7130179ba07c44898
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351968/?tool=EBI
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351968/?tool=EBI
Adenomatous Polyposis Coli (APC) is lost in approximately 70% of sporadic breast cancers, with an inclination towards triple negative breast cancer (TNBC). TNBC is treated with traditional chemotherapy, such as paclitaxel (PTX); however, tumors often
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0803ebe51d4854421a802128f416eef7
https://doi.org/10.1101/2020.10.31.362608
https://doi.org/10.1101/2020.10.31.362608
Publikováno v:
Cancer Research. 81:1403-1403
Triple negative breast cancer (TNBC) accounts for about 20% of all breast cancers. TNBC is an aggressive subtype of breast cancer that lacks the expression of estrogen and progesterone receptors and HER2 protein. This lack of functioning receptors re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71149844a782d9794f26346aa89df761
https://doi.org/10.1158/1538-7445.am2021-1403
https://doi.org/10.1158/1538-7445.am2021-1403
Publikováno v:
Cancers
Cancers, Vol 12, Iss 3323, p 3323 (2020)
Cancers, Vol 12, Iss 3323, p 3323 (2020)
Simple Summary Drug resistance is prevalent in many types of cancer and decreases patient survival. The taxanes are anti-mitotic chemotherapeutic agents, widely used since the 1990s to treat many types of cancer. Even with the popularity of the taxan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25529670e575dad4fb38bcdc07589f29
https://doi.org/10.3390/cancers12113323
https://doi.org/10.3390/cancers12113323